GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Indofarma Tbk (ISX:INAF) » Definitions » Cyclically Adjusted Revenue per Share

PT Indofarma Tbk (ISX:INAF) Cyclically Adjusted Revenue per Share : Rp614.26 (As of Sep. 2023)


View and export this data going back to 2001. Start your Free Trial

What is PT Indofarma Tbk Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

PT Indofarma Tbk's adjusted revenue per share for the three months ended in Sep. 2023 was Rp26.373. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is Rp614.26 for the trailing ten years ended in Sep. 2023.

During the past 12 months, PT Indofarma Tbk's average Cyclically Adjusted Revenue Growth Rate was -2.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of PT Indofarma Tbk was 4.40% per year. The lowest was 4.40% per year. And the median was 4.40% per year.

As of today (2024-06-12), PT Indofarma Tbk's current stock price is Rp153.00. PT Indofarma Tbk's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2023 was Rp614.26. PT Indofarma Tbk's Cyclically Adjusted PS Ratio of today is 0.25.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PT Indofarma Tbk was 10.07. The lowest was 0.21. And the median was 1.80.


PT Indofarma Tbk Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for PT Indofarma Tbk's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Indofarma Tbk Cyclically Adjusted Revenue per Share Chart

PT Indofarma Tbk Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 552.84 560.86 617.44 628.86

PT Indofarma Tbk Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 631.65 628.86 616.19 620.01 614.26

Competitive Comparison of PT Indofarma Tbk's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, PT Indofarma Tbk's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Indofarma Tbk's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Indofarma Tbk's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where PT Indofarma Tbk's Cyclically Adjusted PS Ratio falls into.



PT Indofarma Tbk Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PT Indofarma Tbk's adjusted Revenue per Share data for the three months ended in Sep. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=26.373/128.1514*128.1514
=26.373

Current CPI (Sep. 2023) = 128.1514.

PT Indofarma Tbk Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201309 95.073 90.474 134.666
201312 224.767 91.196 315.849
201403 50.055 92.483 69.360
201406 74.993 93.015 103.322
201409 130.722 94.576 177.130
201412 189.916 98.819 246.288
201503 62.877 98.388 81.898
201506 86.402 99.766 110.985
201509 107.329 101.037 136.132
201512 266.668 102.133 334.602
201603 65.057 102.764 81.129
201606 86.987 103.212 108.006
201609 128.167 104.142 157.715
201612 259.548 105.222 316.108
201703 67.093 106.476 80.751
201709 0.000 108.020 0.000
201712 274.862 109.017 323.105
201803 48.113 110.097 56.003
201806 57.304 111.085 66.108
201809 130.681 111.135 150.691
201812 275.484 112.430 314.006
201903 43.998 112.829 49.973
201906 75.002 114.730 83.776
201909 69.224 114.905 77.205
201912 250.265 115.486 277.712
202003 47.777 116.252 52.667
202006 96.055 116.630 105.544
202009 97.428 116.397 107.267
202012 311.794 117.318 340.585
202103 121.022 117.840 131.612
202106 153.624 118.184 166.580
202109 202.617 118.262 219.561
202112 453.054 119.516 485.788
202203 109.390 120.948 115.905
202206 75.833 123.322 78.802
202209 106.749 125.298 109.180
202212 77.183 126.098 78.440
202303 54.786 126.953 55.303
202306 62.650 127.663 62.890
202309 26.373 128.151 26.373

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


PT Indofarma Tbk  (ISX:INAF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

PT Indofarma Tbk's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=153.00/614.26
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PT Indofarma Tbk was 10.07. The lowest was 0.21. And the median was 1.80.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


PT Indofarma Tbk Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of PT Indofarma Tbk's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Indofarma Tbk (ISX:INAF) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Jalan Indofarma No. 1, Cikarang Barat, Jawa Bara, Bekasi, IDN, 17530
PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others, Pharmaceutical Engineering, and Aliansi Strategis Segment. The Medicine business segment includes drug production, marketing and distribution and sales. The Medical Device Segment includes medical devices and other products. The Pharmaceutical Engineering Segment includes the sale and maintenance of packaging machines for the pharmaceutical industry to external parties.

PT Indofarma Tbk (ISX:INAF) Headlines

No Headlines